We are live on
!
Find out more
OAM
Oxford Asset Management Portfolio holdings
AUM
$232M
1-Year Est. Return
31%
This Fund
S&P 500
This Quarter
Est. Return
+8.76%
1 Year Est. Return
+31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.02B
AUM Growth
+$915M
(+22%)
Cap. Flow
+$807M
Cap. Flow
% of AUM
16.08%
Top 10 Holdings %
Top 10 Hldgs %
23.32%
Holding
1,875
New
492
Increased
516
Reduced
411
Closed
433
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$152M |
| 2 |
RICE
Rice Energy Inc.
RICE
|
+$127M |
| 3 |
AABA
Altaba Inc
AABA
|
+$120M |
| 4 |
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
|
+$78.4M |
| 5 |
ALR
Alere Inc
ALR
|
+$59.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WWAV
The WhiteWave Foods Company
WWAV
|
+$104M |
| 2 |
OKS
Oneok Partners LP
OKS
|
+$86.4M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$84.7M |
| 4 |
SWC
Stillwater Mining Co
SWC
|
+$50.9M |
| 5 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$38.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.46% |
| 2 | Healthcare | 13.87% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Industrials | 11.63% |
| 5 | Energy | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
LPL Financial
LPLA
$28.3B
| $4.67M | 0.09% |
110,103
+27,077
| +33% | +$1.1M |
|
|
CBM
227
DELISTED
Cambrex Corporation
CBM
| $4.67M | 0.09% |
+78,160
| New | +$4.39M |
|
228
Boston Properties
BXP
$11.2B
| $4.6M | 0.09% |
+37,419
| New | +$4.73M |
|
229
Worthington Enterprises
WOR
$2.75B
| $4.58M | 0.09% |
+147,842
| New | +$3.97M |
|
230
Charles River Laboratories
CRL
$11.2B
| $4.57M | 0.09% |
45,157
+10,532
| +30% | +$969K |
|
231
AbbVie
ABBV
$443B
| $4.55M | 0.09% |
62,775
-18,855
| -23% | -$1.27M |
|
|
ARRS
232
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $4.51M | 0.09% |
160,959
+98,367
| +157% | +$2.7M |
|
|
CRC
233
DELISTED
California Resources Corporation
CRC
| $4.51M | 0.09% |
527,372
+136,442
| +35% | +$1.61M |
|
234
Vertex Pharmaceuticals
VRTX
$121B
| $4.49M | 0.09% |
34,803
+2,042
| +6% | +$246K |
|
235
Lazard
LAZ
$4.13B
| $4.46M | 0.09% |
96,352
+63,934
| +197% | +$2.87M |
|
|
APTI
236
DELISTED
Apptio, Inc. Class A Common Stock
APTI
| $4.46M | 0.09% |
+257,155
| New | +$3.78M |
|
237
WEC Energy
WEC
$35.7B
| $4.45M | 0.09% |
+72,542
| New | +$4.48M |
|
238
Microsoft
MSFT
$3.45T
| $4.43M | 0.09% |
64,322
+42,579
| +196% | +$2.92M |
|
239
VeriSign
VRSN
$26.2B
| $4.42M | 0.09% |
47,547
+23,796
| +100% | +$2.15M |
|
|
SCLN
240
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $4.4M | 0.09% |
+400,000
| New | +$4M |
|
241
Donnelley Financial Solutions
DFIN
$1.16B
| $4.38M | 0.09% |
190,579
+130,750
| +219% | +$2.86M |
|
242
Nu Skin
NUS
$252M
| $4.37M | 0.09% |
69,496
-16,708
| -19% | -$952K |
|
|
PRAH
243
DELISTED
PRA Health Sciences, Inc.
PRAH
| $4.36M | 0.09% |
58,096
+21,579
| +59% | +$1.5M |
|
244
Invesco
IVZ
$13.1B
| $4.36M | 0.09% |
123,794
+61,249
| +98% | +$2M |
|
|
EVRI
245
DELISTED
Everi Holdings
EVRI
| $4.34M | 0.09% |
596,734
+135,797
| +29% | +$879K |
|
246
Cable One
CABO
$227M
| $4.34M | 0.09% |
+6,107
| New | +$4.19M |
|
|
IPG
247
DELISTED
Interpublic Group of Companies
IPG
| $4.34M | 0.09% |
+176,288
| New | +$4.31M |
|
248
CubeSmart
CUBE
$9.39B
| $4.32M | 0.09% |
179,500
+81,032
| +82% | +$2.05M |
|
|
ANDV
249
DELISTED
Andeavor
ANDV
| $4.31M | 0.09% |
+46,037
| New | +$3.88M |
|
|
UNIT
250
Uniti Group
UNIT
$2.36B
| $4.3M | 0.09% |
171,115
-19,947
| -10% | -$517K |
|
Similar funds
5SA
KG
BCM
VOMP
SOAG
TLA
RWS
SC
Oxford Asset Management's Q2 2017 Portfolio in Review
As of Q2 2017, Oxford Asset Management held 1,875 positions worth $5.02B, up 22% from $4.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Oxford Asset Management deployed $807M of net new capital in Q2 2017, opening 492 new positions and adding to 516 existing holdings. Its largest new stake was CR Bard Inc.: 511,170 shares worth $162M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $32M trimmed.
- Oxford Asset Management's largest Q2 2017 buy was CR Bard Inc.: 511,170 shares worth $162M.
- Oxford Asset Management added most to Rice Energy Inc. in Q2 2017, an estimated $127M increase.
- Oxford Asset Management's biggest Q2 2017 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $32M.
- Oxford Asset Management fully exited The WhiteWave Foods Company in Q2 2017, selling an estimated $104M.
- Oxford Asset Management's ten largest holdings make up 23% of its $5.02B portfolio in Q2 2017.
- Oxford Asset Management opened 492 new positions and closed 433 in Q2 2017.
- Oxford Asset Management's portfolio value rose 22% quarter-over-quarter to $5.02B.
Based on Oxford Asset Management's 13F filing for Q2 2017, filed 11 Aug 2017.